CN
CureVac N.V.
CVAC
NASDAQHealth Care
$4.66
USD
+0.00(0.00%)
At close: Apr 29, 20:00 UTC
Loading chart…
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
Market Cap
$1.05B
P/E Ratio
7.0
EPS
0.84
Revenue
$592.82M
Employees
904
About
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Tuebingen, Baden-Wuerttemberg and currently employs 825 full-time employees. The firm was founded in 2020.
Why CVAC moved
emptyResult
About
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Tuebingen, Baden-Wuerttemberg and currently employs 825 full-time employees. The firm was founded in 2020.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.